Global bird flu vaccination push as H5N1 spreads to new continents

864 human H5N1 cases reported since 2003 with 456 deaths; virus recently transmitted to mammals raising pandemic risk concerns.
We cannot assume that will remain the case. We must prepare.
WHO director-general on the risk of H5N1 jumping to humans and the need for preventive action.

A virus that has claimed nearly half the lives it has touched in humans is now pressing at the edges of every continent, forcing governments to reconsider long-held trade priorities in favor of biosecurity. H5N1 bird flu, having devastated poultry populations and quietly crossed into mammals, is compelling the European Union, the United States, and potentially Australia to pursue avian vaccination programs once dismissed as economically inconvenient. The moment marks a quiet but significant shift in how nations weigh the cost of prevention against the cost of waiting.

  • H5N1 has reached every continent except Australia and Antarctica, infecting nearly 60 million birds in the worst outbreak on record and driving egg and food prices to historic highs.
  • The virus has already leapt from birds to mammals — minks, capable of hosting both avian and human flu strains, now represent a potential biological crucible where a pandemic-capable mutation could emerge.
  • With 864 human cases and a 50% fatality rate since 2003, the WHO is urging close surveillance even as it currently assesses human risk as low — a fragile reassurance that experts warn could change without notice.
  • The EU and Biden administration are now actively weighing bird vaccination programs, reversing years of resistance rooted in export market concerns, with Australia signaling it may follow if the outbreak reaches its shores.
  • Scientists are threading a careful public message — serious vigilance without panic — insisting this is not yet a Covid-19 scenario, but that the window for proactive action is narrowing.

H5N1 bird flu has now reached every continent except Australia and Antarctica, and the pressure on governments to vaccinate poultry flocks — long resisted for trade reasons — is becoming difficult to ignore. The European Union and the Biden administration are both seriously considering avian vaccine programs, and Australia's agricultural authorities have signaled they would move in the same direction if the virus arrived at their borders. The question, experts suggest, is no longer whether such programs will come, but when.

The scale of the outbreak is staggering. Nearly 60 million birds have been infected in what is the worst recorded episode of its kind, with egg prices spiking and food supply chains under strain. But the more unsettling concern lies beneath the economics. Since 2003, the WHO has recorded 864 human H5N1 infections and 456 deaths — a fatality rate of roughly 50 percent. The virus has already demonstrated it can cross from birds into mammals, with minks emerging as a particularly worrying host, capable of carrying both avian and human influenza strains and potentially serving as a site where dangerous mutations could develop.

Experts are calibrating their language carefully. The WHO's director-general has assessed the current human risk as low, but explicitly warned that this cannot be assumed to hold. Australian infectious disease specialist Peter Collignon echoed that measured tone — urging vigilance without alarm, and distinguishing the current situation from a Covid-19-level threat. The shift in vaccination policy reflects a broader recalculation: the trade-offs that once made inaction seem reasonable are being reweighed as the biological and economic costs of the outbreak continue to mount.

The virus is everywhere now except at the bottom of the world. H5N1 bird flu has swept across every continent but Australia and Antarctica, and scientists are pushing governments to do something they've long resisted: vaccinate birds against it.

For years, countries including Australia blocked poultry vaccination over trade concerns—the fear that vaccinated flocks would complicate export markets. That calculus is shifting. The European Union and the Biden administration are now seriously considering avian vaccine programs. Australia's Department of Agriculture, Fisheries and Forestry signaled the same door could open there: "If Australia were also suffering or facing such losses, we would be encouraging our own industry to adopt vaccination." The implication was clear. It's not a question of if, but when.

Ian Barr, deputy director of the WHO Collaborating Centre for Reference and Research on Influenza, laid out the geography of the crisis. The virus is deeply entrenched in the Northern Hemisphere and has begun moving into South America for the first time. That trajectory worries experts. If it's reaching new continents, Australia's isolation may not hold much longer.

The immediate damage is economic and visible. Nearly 60 million birds have been infected in what amounts to the worst outbreak on record, particularly in the United States. Egg prices have spiked to record levels in some nations. Supplies of chicken, pork, and bacon face disruption. But the deeper fear is biological. Since 2003, the WHO has documented 864 human cases of H5N1 infection, with 456 deaths—a fatality rate hovering around 50 percent. The virus has already jumped from birds to mammals. Minks, it turns out, are susceptible to both avian and human influenza strains, making them potential mixing vessels where the virus could acquire the mutations needed to spread easily among people.

Peter Collignon, an infectious diseases expert at Australian National University, offered measured concern. "I think we need to be concerned and monitor what's going on," he said. "I don't think we need to have a view that the world will end tomorrow because this is going to be worse than Covid-19." That distinction matters. The WHO's director-general, Tedros Adhanom Ghebreyesus, recently assessed the current risk to humans as low. But he added a crucial caveat: "We cannot assume that will remain the case. And we must prepare for any change in the status quo."

The spillover to mammals is the hinge point. It's being watched closely, not because it guarantees pandemic spread, but because it proves the virus can cross species barriers. Vaccination of birds—preventing the reservoir of infection in poultry—is now seen as a way to reduce that risk before it becomes unmanageable. The old trade-off between economic convenience and biosecurity has been reweighed. The cost of inaction is starting to look higher than the cost of change.

The virus is extremely widespread in the Northern Hemisphere and is now starting to move into South America, which it's never done before.
— Ian Barr, WHO Collaborating Centre for Reference and Research on Influenza
We cannot assume that will remain the case. And we must prepare for any change in the status quo.
— Tedros Adhanom Ghebreyesus, WHO director-general
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why did countries wait so long to consider vaccinating birds if the risk was always there?

Model

Trade. A vaccinated flock creates complications for export markets—importing countries worry about disease status, certification becomes messier. When the virus was contained in certain regions, that friction seemed worse than the risk. Now the virus is everywhere, and the friction looks trivial.

Inventor

So this is about the minks you mentioned—they're the real worry?

Model

They're one worry. Minks can carry both bird flu and human flu at the same time. That's the scenario scientists lose sleep over: a virus that learns to move between species inside a single animal. It's not inevitable, but it's possible.

Inventor

If the fatality rate is 50 percent, why isn't there more panic?

Model

Because human cases are still rare. Eight hundred sixty-four cases in twenty years is tiny. The virus is good at killing birds and occasionally jumping to humans, but it's not yet good at spreading human-to-human. That's what everyone's watching for—the moment it learns that trick.

Inventor

And vaccination of birds prevents that?

Model

It reduces the opportunity. Fewer infected birds means fewer chances for the virus to circulate, mutate, and adapt. It's not a guarantee, but it's the most direct lever we have right now.

Inventor

What happens if it reaches Australia?

Model

The government has already signaled it would reverse its vaccination ban. Australia's isolation has bought time, but everyone knows that's temporary. When it arrives, the response will be swift.

Quer a matéria completa? Leia o original em NEWS.com.au ↗
Fale Conosco FAQ